Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
NCT01080521 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 247
Last updated 2018-04-12
Summary
This clinical trial is studying changes in brain function in patients with stage I, stage II, stage III, or stage IV ovarian, primary peritoneal, or fallopian tube cancer who are receiving chemotherapy. Learning about the effects of chemotherapy on brain function may help doctors plan cancer treatments.
Conditions
- Cognitive Side Effects of Cancer Therapy
- Malignant Ovarian Epithelial Tumor
- Ovarian Brenner Tumor
- Ovarian Carcinosarcoma
- Ovarian Choriocarcinoma
- Ovarian Clear Cell Cystadenocarcinoma
- Ovarian Dysgerminoma
- Ovarian Embryonal Carcinoma
- Ovarian Endometrioid Adenocarcinoma
- Ovarian Mixed Germ Cell Tumor
- Ovarian Mucinous Cystadenocarcinoma
- Ovarian Polyembryoma
- Ovarian Sarcoma
- Ovarian Seromucinous Carcinoma
- Ovarian Serous Cystadenocarcinoma
- Ovarian Teratoma
- Ovarian Yolk Sac Tumor
- Stage I Ovarian Cancer
- Stage IA Fallopian Tube Cancer
- Stage IA Ovarian Cancer
- Stage IA Ovarian Germ Cell Tumor
- Stage IB Fallopian Tube Cancer
- Stage IB Ovarian Cancer
- Stage IB Ovarian Germ Cell Tumor
- Stage IC Fallopian Tube Cancer
- Stage IC Ovarian Cancer
- Stage IC Ovarian Germ Cell Tumor
- Stage II Ovarian Cancer
- Stage IIA Fallopian Tube Cancer
- Stage IIA Ovarian Cancer
- Stage IIA Ovarian Germ Cell Tumor
- Stage IIB Fallopian Tube Cancer
- Stage IIB Ovarian Cancer
- Stage IIB Ovarian Germ Cell Tumor
- Stage IIC Fallopian Tube Cancer
- Stage IIC Ovarian Cancer
- Stage IIC Ovarian Germ Cell Tumor
- Stage IIIA Fallopian Tube Cancer
- Stage IIIA Ovarian Cancer
- Stage IIIA Ovarian Germ Cell Tumor
- Stage IIIA Primary Peritoneal Cancer
- Stage IIIB Fallopian Tube Cancer
- Stage IIIB Ovarian Cancer
- Stage IIIB Ovarian Germ Cell Tumor
- Stage IIIB Primary Peritoneal Cancer
- Stage IIIC Fallopian Tube Cancer
- Stage IIIC Ovarian Cancer
- Stage IIIC Ovarian Germ Cell Tumor
- Stage IIIC Primary Peritoneal Cancer
- Stage IV Fallopian Tube Cancer
- Stage IV Ovarian Cancer
- Stage IV Ovarian Germ Cell Tumor
- Stage IV Primary Peritoneal Cancer
- Undifferentiated Ovarian Carcinoma
Interventions
- PROCEDURE
-
Cognitive Assessment
Ancillary studies
- OTHER
-
Quality-of-Life Assessment
Ancillary studies
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Gynecologic Oncology Group
lead NETWORK
Principal Investigators
-
Lisa Hess · Gynecologic Oncology Group
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-04-30
- Primary Completion
- 2012-01-31
- Completion
- 2018-01-27
Countries
- United States
Study Locations
More Related Trials
-
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NCT00958698 ·Status: UNKNOWN ·Phase: NA
-
Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
NCT00003794 ·Status: TERMINATED
-
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer
NCT05415709 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer
NCT03949283 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer
NCT01970722 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT00719303 ·Status: UNKNOWN ·Phase: PHASE3
-
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer
NCT02065687 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer
NCT00017017 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers
NCT05691504 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
NCT00565851 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer
NCT05691010 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
NCT00942357 ·Status: UNKNOWN ·Phase: PHASE3
-
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
NCT02502266 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer
NCT05276973 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
NCT01295489 ·Status: COMPLETED
-
Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
NCT00003358 ·Status: COMPLETED ·Phase: PHASE1
-
Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer
NCT00402935 ·Status: WITHDRAWN
-
Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer
NCT02345265 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer
NCT00008138 ·Status: COMPLETED ·Phase: PHASE2
-
DOD Long-Term Survivors of Ovarian Cancer
NCT02321735 ·Status: UNKNOWN ·Phase: NA
-
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer
NCT01081262 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer
NCT00039559 ·Status: UNKNOWN ·Phase: NA
-
Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
NCT00085358 ·Status: COMPLETED ·Phase: PHASE1
-
Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer
NCT00993655 ·Status: COMPLETED ·Phase: PHASE2
-
Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT02627443 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1